Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· ARTC-Dr. Max MacCloud

The Rapamycin Controversy: Can It Really Extend Your Life?

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

Rapamycin is a drug transitioning from transplant medicine to longevity research. Understand the risks and potential benefits of this molecule. This analysis examines why Rapamycin has become a polarizing topic in the medical community. We break down the clinical evidence and explore the stark contrast in perspectives between specialized longevity clinics and conventional primary care physicians. This content is designed for those looking for a balanced, factual overview of how this compound is currently being studied for age-related applications. By comparing these viewpoints, you will gain a clearer picture of the current state of longevity research and the practical realities of prescribing such treatments. We focus on the data to help you distinguish between hype and clinical observation regarding this transplant drug. Our goal is to provide clarity on the safety profile and potential future utility of these therapies.

ARTC-Dr. Max MacCloud · 9 min · Source published: 2026-08-28

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…